MYL3/CMLC1 antibody (C-Term)
Quick Overview for MYL3/CMLC1 antibody (C-Term) (ABIN8012852)
Target
See all MYL3/CMLC1 (MYL3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- Anti-MYL3 Antibody
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Characteristics
- Anti-MYL3 Antibody. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human MYL3, which shares 91.3% amino acid (aa) sequence identity with both mouse and rat MYL3.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing. -
Expiry Date
- 12 months
-
-
- MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))
-
Alternative Name
- MYL3
-
Background
-
Background: Myosin essential light chain (ELC), ventricular/cardiac isoform is a protein that in humans is encoded by the MYL3 gene. MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
Gene Full Name: myosin light chain 3
-
Molecular Weight
- 25 kDa
-
Gene ID
- 4634
-
UniProt
- P08590
Target
-